Skip to main content
INSM
NASDAQ Life Sciences

Insmed Q2 Revenue Soars 49% on BRINSUPRI Launch, Guidance Raised

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$118
Mkt Cap
$21.463B
52W Low
$90.39
52W High
$212.75
52W Position info
31% above low
Off High info
45% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

INSM sits 31% above its 52-week low of $90.39.

Summary

Insmed delivered a massive Q2 beat with revenue of $425.5M, well above the $392.84M consensus, driven by a 49% sequential jump in BRINSUPRI sales. Net loss narrowed dramatically to $13.2M from $321.7M a year ago, signaling a rapid path to profitability. Management raised 2026 BRINSUPRI guidance to $1.25B-$1.40B and lifted the peak revenue estimate for its three lead programs to over $14B. This follows the positive 12-month TPIP data in July and the shelf filing in May, but today's numbers materially reset the growth trajectory. The stock closed at $99.02 yesterday, leaving significant room versus the $198 analyst median target.

Updates

  1. · dpa-AFX — Insmed shares jumped 33% following the Q2 report.

At the time of this announcement, INSM was trading at $118.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.5B. The 52-week trading range was $90.39 to $212.75. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INSM - Latest Insights

INSM
Oct 30, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $110.91
Real-time Price: $122.88 info
Change: +$11.97 (+11%) info
Market Cap: $26.957B info
INSM
Oct 29, 2026, 12:51 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $110.63
Real-time Price: $122.88 info
Change: +$12.25 (+11%) info
Market Cap: $26.957B info
INSM
Oct 29, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $122.88 info
Change: +$24.11 (+24%) info
Market Cap: $26.957B info
INSM
Oct 29, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $122.88 info
Change: +$24.11 (+24%) info
Market Cap: $26.957B info
INSM
Oct 15, 2026, 8:54 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $96.60
Real-time Price: $122.88 info
Change: +$26.28 (+27%) info
Market Cap: $26.957B info